Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Jodie L. Simpson et al.|The Lancet Respiratory Medicine|2021Cited by 434
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s diseaseSandra Sanabria Bohórquez, Robby M. Weimer, Jan Mařı́k et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 130
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Mona Bafadhel, Richard Russell et al.|The Lancet Respiratory Medicine|2024Cited by 98
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Dan V. Nicolau et al.|medRxiv|2021Cited by 25
P4‐351: Evaluation of TAU Burden in a Cross‐Sectional Cohort of Alzheimer’S Disease Subjects Using [<sup>18</sup>F]GTP1 (GENENTECH TAU PROBE 1)Sandra Sanabria Bohórquez, Geoffrey A. Kerchner, Olivier Barret et al.|Alzheimer s & Dementia|2016Cited by 14